Table 2.5 – Chronic – Case Rates by Jurisdiction

At a glance

In 2022, the highest rate of newly reported chronic hepatitis B was in Rhode Island (33.3 cases per 100,000 population), whereas the lowest rate was in New Hampshire (0.1 cases per 100,000 population).
2022 Hepatitis B Surveillance

Number and rate* of newly reported cases† of chronic hepatitis B, by state or jurisdiction — United States, 2022

Table 3.4. Number of newly reported cases* of perinatal Hepatitis C virus infection, by state or jurisdiction — United States, 2021
Table 2.5 Data
Number and rate* of newly reported cases† of chronic hepatitis B, by state or jurisdiction — United...
Download
Download

Source: CDC, National Notifiable Diseases Surveillance System.

* Rates per 100,000 population.

† Reported confirmed cases. For case definition, see Chronic Hepatitis B.

—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.

N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.

U: Unavailable. The data were unavailable.

Summary

In the United States, chronic hepatitis B is one of the leading causes of cirrhosis and liver cancer. This table displays the numbers and rates of newly reported chronic hepatitis B cases during 2022, by state or jurisdiction. In 2022, chronic hepatitis B was not a reportable condition in four states (Connecticut, Kentucky, Mississippi, and Texas), and cases were unavailable from two states (Arkansas and Hawaii). The highest rate of newly reported chronic hepatitis B was in Rhode Island (33.3 cases per 100,000 population), whereas the lowest rate was in New Hampshire (0.1 cases per 100,000 population). Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B virus (HBV) infections, which is not captured in the National Notifiable Diseases Surveillance System (NNDSS).

Print
Content Source:
About Division of Viral Hepatitis